Navigation Links
Heart Hospital of Austin Physician First in Texas to Implant New Heart Failure Device
Date:12/1/2011

AUSTIN, Texas, Dec. 1, 2011 /PRNewswire/ -- On November 30, 2011, a physician at Heart Hospital of Austin became the first in Texas to implant the Unify Quadra cardiac resynchronization therapy defibrillator (CRT-D) and Quartet® Left Ventricular Quadripolar Pacing Lead. The new pacing technology, developed by St. Jude Medical, offers additional pacing options that can reduce the need for reoperation to reposition a lead. This new technology offers physicians the ability to more efficiently and effectively manage the individualized needs of patients with heart failure.

David R. Tschopp, M.D., director of electrophysiology at Heart Hospital of Austin, implanted the Unify Quadra quadripolar pacing system to regulate and resynchronize the heartbeat of a heart failure patient. The patient was diagnosed with non-ischemic dilated cardiomyopathy, a condition resulting in decreased blood supply due to the heart's main pumping chamber—the left ventricle—being enlarged, dilated and weak. Unify Quadra was determined to be the best fit because of the patient's condition and the device's ability to optimize the delivery of therapy.  The procedure was performed at Heart Hospital of Austin.

"This technology is the industry's first quadripolar pacing system, and the Heart Hospital of Austin is proud to be among the first hospitals in the country to implant this state-of-the-art device," Dr. Tschopp said. "We are committed to providing our patients with smart technology that will help improve their quality of life. We recognize the advancements found in St. Jude Medical's latest CRT device and are excited to have the Unify Quadra as an option for our patients."

CRT-Ds, such as the Unify Quadra CRT-D, are designed to optimize the heart's pumping function and help the heart perform in its most natural state by synchronizing the left and right ventricles of the heart through timed electrical pulses.

The Qu
'/>"/>

SOURCE Heart Hospital of Austin
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Many Heart Attack Patients Dont Get Best Emergency Treatment
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
4. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
5. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
6. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
7. Its Only Heartburn...or is it? Chronic Heartburn a Risk Factor for Precursor to Esophageal Cancer
8. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
11. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 The role of the Medical Science ... thing hasn,t changed: face-to-face meetings are seen as the ... Opinion Leaders. Yet at the same time ... of interaction, field medical teams within the pharmaceutical sector ... is just one of the challenges addressed in " ...
(Date:2/27/2015)... SUNNYVALE, Calif. , Feb. 27, 2015 /PRNewswire/ ... highlighted findings from a pre-clinical study published in ... Sciences ( www.pnas.org/cgi/doi/10.1073/pnas.1500712112 ) that showed when ... anti-PD-L1 antibody (a checkpoint inhibitor), suppression of tumor ... be achieved when treating certain hematologic cancers and ...
(Date:2/27/2015)... February 27, 2015 ... dell,innovativo sistema di monitoraggio dell,infarto congestizio (CHF - ...     Vectorious ... nuovo sistema per il monitoraggio cardiaco destinato a ... oggi di aver concluso una raccolta di finanziamenti ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
(Date:2/28/2015)... (PRWEB) February 28, 2015 Gerald “Solutionman” ... main blocks or barriers to innovative thinking. “The ... block was lack of tools,” reports Haman, who created ... that 57% of people felt that they did not ... more tools and resources to stimulate innovation. , Solutionman’s ...
(Date:2/28/2015)... March—also known as National Brain ... ourselves and others that suspected head injuries, especially ... (ANS). , Concussions are a form of traumatic ... TBIs. There are 1.6-3.8 million sports-related concussions per ... it is a brain injury. Many athletes suffer ...
(Date:2/28/2015)... February 28, 2015 A study out ... new gene therapy procedure for the treatment of a ... patients. Authored by Dr. Robert MacLaren, professor ... in the Lancet Medical Journal on January 16, 2014 ... a rare genetic disorder that mostly affects men and ...
(Date:2/28/2015)... February 28, 2015 National ... outsourced sales, marketing and supply chain management for ... Botanicals, is bringing its award winning solutions for ... Botanicals’ products are specifically created to combat thinning-damaged ... BIOTA is committed to marrying science with nature ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at ... and current student obtaining her Masters degree in social ... forum in psychoeducation on substance use for teens at ... part of her studies. , “Even though these students ... counseling at the high school and junior high school ...
Breaking Medicine News(10 mins):Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2
... ... how to have fun and go green with your mom on Mother,s Day. , ... (Vocus) April 29, 2010 -- Your mom has taught ... Boldrini, is greening Mother,s Day for us. She says: "The biggest gift your mom wants is ...
... ... fast high capacity transport network by 1.4 milliseconds on the route between Chicago and Newark ... ... today announced the completion of a network improvement project designed to significantly reduce the latency ...
... ... culture fodder is ShoeDini, the As Seen On TV shoe horn with a telescoping ... shoes on and off without having to bend over, the commercial calls a spade ... shoe horn on a stick. Featuring a famously annoying voice, the latest ASOTV item ...
... -- Combination antibiotics effectively treat Chlamydia-induced reactive arthritis a ... a federal multicenter clinical trial led by the University of ... sponsored by the National Institute of Musculoskeletal and Skin Diseases, ... and Rheumatism , a journal of the American College of ...
... less likely to have a varus thrust, but more likely ... visualized during gait as the worsening or abrupt onset of ... return to less varus and more neutral alignment during lift-off ... research has shown that varus thrust seen in gait is ...
... cancer therapeutics based on its next generation oncolytic viruses, ... from HealthCap. With committed capital exceeding 800 million, ... venture capital within life sciences in Europe. After ... strong safety and efficacy results, Oncos has selected its ...
Cached Medicine News:Health News:5 Ways to Have a Green Mother's Day 2Health News:5 Ways to Have a Green Mother's Day 3Health News:Network Latency Improvement Creates One of the Fastest Routes between Chicago and Newark/New York City 2Health News:New Product Has More Than Shtick Appeal It's Not Just a Shoe Horn, It's a Shoe Horn on a Stick 2Health News:Combination antibiotics effective against chlamydia-induced arthritis 2Health News:Combination antibiotics effective against chlamydia-induced arthritis 3Health News:Racial disparity observed in varus and valgus thrust study of knee OA 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: